|
Citra Labs’ Rejection Limits Too Wimpy, Form 483 States
Citra Labs, a maker of injectable anticoagulants, received a lengthy, 28-observation Form 483 noting various visual inspection shortfalls, including a lack of a rejection limit for glass particles.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives